Medical device commercialization
4 European H2020 organizations list this as part of their work.
Most active in this area
- NORAKER
French SME developing bioactive glass implants for bone regeneration surgery, from material science through clinical-stage commercialization.
“Successfully progressed through SME Instrument Phase 1 (feasibility) to Phase 2 (commercialization), indicating active market-readiness trajectory.”
SMEFR3 projects - BLOOM TECHNOLOGIES
Belgian MedTech SME developing wearable biosensors for early detection of preterm labour in obstetric monitoring.
“Securing SME Instrument Phase 2 (€1.26M) requires a credible go-to-market plan, suggesting capability in regulatory strategy and clinical validation pathways.”
SMEBE2 projects - NUKUTE OY
Finnish medtech SME developing non-invasive remote screening and therapy devices for sleep apnea and sleeping disorders.
“Completing both SME Instrument Phase 1 (feasibility) and Phase 2 (market pilot) for the same product demonstrates systematic commercialization expertise.”
SMEFI2 projects - TECNIMUSA S.L.
Spanish SME developing a wearable robotic exoskeleton for autonomous walking in people with paraplegia.
“Successful progression from SME Instrument Phase 1 (feasibility, €50K) to Phase 2 (full development, €1.34M) indicates a commercially focused development path, not pure research.”
SMEES2 projects